Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isoflurane vs Midazolam for Prolonged Sedation in Septic Shock
NCT04710914Phase 4Terminated
- Sponsor
- Rouen University Hospital
- Start
- Dec 2020
- Primary completion
- Dec 2020
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of isoflurane in septic shock (2 arms), sponsored by Rouen University Hospital. Primary endpoint: Delay between the first sedation stop and extubation at 10 days. Started Dec 2020; status: terminated.
02
Drugs
isoflurane
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT04710914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04710914.